Papers: 10.1007/s10637-017-0470-z

https://doi.org/10.1007/s10637-017-0470-z

Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia

Cited by: 167
Author(s): Masamichi Mori, Naoki Kaneko, Yoshio Ueno, Masaki Yamada, Ray Tanaka, Rika Saito, Ichio Shimada, Kenichi Mori, Sadao Kuromitsu
Published: about 8 years ago

Software Mentions 1